fluoxetine has been researched along with Hyperprolactinemia in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperprolactinemia was defined as a serum prolactin level greater than 16." | 2.72 | Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. ( Fava, M; Hilliker, SE; Klibanski, A; Miller, KK; Papakostas, GI; Petersen, T; Sklarsky, KG, 2006) |
| "Risperidone (N=45, 62%) was the most frequently prescribed antipsychotic drug, followed by olanzapine (24, 32%)." | 1.35 | Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. ( Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houston, JP | 1 |
| Fijal, B | 1 |
| Heinloth, AN | 1 |
| Adams, DH | 1 |
| Papakostas, GI | 1 |
| Miller, KK | 1 |
| Petersen, T | 1 |
| Sklarsky, KG | 1 |
| Hilliker, SE | 1 |
| Klibanski, A | 1 |
| Fava, M | 1 |
| Alacqua, M | 1 |
| Trifirò, G | 1 |
| Arcoraci, V | 1 |
| Germanò, E | 1 |
| Magazù, A | 1 |
| Calarese, T | 1 |
| Di Vita, G | 1 |
| Gagliano, C | 1 |
| Spina, E | 1 |
| Arya, DK | 1 |
| Taylor, WS | 1 |
| Snowden, H | 1 |
| Woolridge, M | 1 |
| Renfrew, M | 1 |
| Iancu, I | 1 |
| Ratzoni, G | 1 |
| Weitzman, A | 1 |
| Apter, A | 1 |
2 trials available for fluoxetine and Hyperprolactinemia
| Article | Year |
|---|---|
Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Depression; Dose-Response | 2010 |
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.
Topics: Adult; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hyperprolactinemia; Male; Middle Aged | 2006 |
5 other studies available for fluoxetine and Hyperprolactinemia
| Article | Year |
|---|---|
Drug-related hyperprolactinemia.
Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; H | 2003 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Ut | 2008 |
Lactation associated with fluoxetine treatment.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Dru | 1995 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Fluoxetine; Galactorrhea; HIV Infections; HIV Protease Inhibitors | 2001 |
More fluoxetine experience.
Topics: Adolescent; Bulimia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Gala | 1992 |